Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Product
6.1 Introduction
6.2 Plasmid DNA
6.3 Viral Vectors
6.4 Non-Viral Vectors
6.5 Others
Chapter 7 Global Viral Vectors and Plasmid DNA Manufacturing, By application
7.1 Introduction
7.2 Cancer
7.3 Inherited Disorder
7.4 Viral Infection
7.5 Others
Chapter 8 Market Segmentation, By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 U.K
8.2.3 Spain
8.2.4 Italy
8.2.5 France
8.2.6 Russia
8.2.7 Others
8.3 Asia-Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 The Middle East & Africa
8.5.1 Introduction
8.5.2 Middle-East
8.5.3 Africa
8.5.4 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1 GE Healthcare
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4. Strategic Initiative
10.2. Lonza
10.3. FinVector
10.4. Vision Therapies
10.5. Sigma-Aldrich Co. LLC
10.6. Kaneka Corporation
10.7. VGXI, Inc
10.8. VIROVEK
10.9. SIRION Biotech GmbH
10.10. Cobra Biologics
10.11. Novasep
10.12. FUJIFILM
10.13. Diosynth Biotechnologies U.S.A., Inc.,
10.14. Spark Therapeutics
10.15. Sanofi
10.16 UniQure
10.17 Cell and Gene Therapy Catapult
10.18 Brammer Bio
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024 (USD Million)
11.1.1 Market Estimation and Forecast by Product 2018-2024 (USD Million)
11.1.2 Market Estimates and Forecast by Application 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
11.1.4 Market Estimates and Forecast by Company 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
